Substrate
science

Survey Finds Public Support for Small-Scale Solar Geoengineering Tests

A government-backed report indicates Britons favor limited testing of solar radiation modification methods as a potential last resort if emissions reductions fall short.

The Times
1 source·May 31, 4:09 PM(5 hrs ago)·1m read
Survey Finds Public Support for Small-Scale Solar Geoengineering TestsThe Times
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

A government-backed report found that members of the British public support small-scale testing of solar radiation modification techniques that could serve as a backup option if greenhouse gas emissions are not sufficiently reduced. The survey examined attitudes toward approaches that would reflect a portion of incoming sunlight away from Earth.

Respondents indicated they would accept such methods only if deployed at limited scale and only if conventional emissions cuts prove inadequate.

Participants emphasized that any experiments should remain small and reversible. They expressed willingness to consider the approach solely as an emergency measure rather than a primary climate strategy. The report did not detail specific technologies or locations for potential tests. It also did not address regulatory or funding requirements for carrying out such experiments.

Transparency

Confidence65%

Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.

Story details

Related Stories

Ebola Cases in Central Africa Rise from 256 to About 1,000 in Eleven Daysjpost.com
science2 days ago

Ebola Cases in Central Africa Rise from 256 to About 1,000 in Eleven Days

Suspected and confirmed Ebola cases in the Democratic Republic of the Congo and Uganda increased from 256 on 16 May to roughly 1,000 by 27 May. The World Health Organization reported about 240 deaths during the same period.

NA
1 source
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 days ago

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source